Article detail · 2022
Global, regional, and national incidence and mortality of COVID-19 in 237 countries and territories, January 2022: a systematic analysis for World Health Organization COVID-19 Dashboard
Journal
Life CycleISSN 2799-8894
- Year
- 2022
- Type
- article
Data source split
- YÖKSİS YÖKSİS article record
- YÖKSİS venue Life Cycle
- OpenAlex OpenAlex enrichment (abstract, citations, topics)
Abstract
OpenAlex · English
Objective: To estimate global, regional, and national incidences and mortality of the coronavirus disease 2019 (COVID-19) in 237 countries and territories since the outbreak of the COVID-19 pandemic to 31 January, 2022. Methods: Comprehensive estimates were produced through global, regional, and national studies of cumulative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections for the duration of the COVID-19 pandemic. The incidence and mortality rate of COVID-19 was analyzed based on the World Health Organization (WHO) COVID-19 Dashboard data since the outbreak of the COVID-19 pandemic to 31 January, 2022. The number of cumulative total confirmed cases, the number of cumulative total confirmed cases (cumulative incidence) per 100,000, the number of cumulative total death cases, and the number of cumulative total death cases (cumulative death rate) per 100,000 population were calculated according to the WHO regions, World Bank income groups, and each country. Results: A total of 349,641,119 of confirmed COVID-19 cases were reported globally on 31 January, 2022 (cumulative incidence of COVID-19, 4,485.72 per 100,000 population). Europe demonstrated the highest cumulative incidence of COVID-19 (14,039.95 per 100,000 population), followed by the Americas (12,512.57 per 100,000 population) showing a cumulative total death cases and cumulative death rate of COVID-19 of 5,592,266 and 71.75 per 100,000 population, respectively. The Americas presented highest cumulative death rate of COVID-19 (14,039.95 per 100,000 population), followed by Europe (12,512.57 per 100,000 population). The nation with the highest cumulative total cases of COVID-19 was the United States of America (n=69,727,991). However, the cumulative death rate of the COVID-19 was found higher in developing and underdeveloped countries. Conclusion: From the start of the COVID-19 pandemic to 31 January, 2022, 349.6 million of the worldwide population suffered symptoms of SARS-COV-2 and 5.6 million lost their lives due to it. The population in Europe and other high-income groups showed high incidence rates of COVID-19 while the death rate was high in Americas and other upper middle-income nations. According to figures of nationalities, the countries with compromised economic status presented a higher death rate despite relatively lower incidence of COVID-19 than the developed countries. The results of this study may provide crucially important for COVID-19 research and proper public health policies and strategies.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
55 citations
OpenAlex cited_by_count (cache / database)
14 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- A systematic review and meta‐analysis of long‐term sequelae of COVID‐19 2‐year after SARS‐CoV‐2 infection: A call to action for neurological, physical, and psychological sciences 2023
- Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19 2024
- Acute and post-acute respiratory complications of SARS-CoV-2 infection: population-based cohort study in South Korea and Japan 2024
- The effect of SARS‐CoV‐2 infection on cardiac function in post‐COVID‐19 survivors: A systematic review and meta‐analysis 2022
- Is the frequency of breakfast consumption associated with life satisfaction in children and adolescents? A cross-sectional study with 154,151 participants from 42 countries 2024
- Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK 2024
- National Trends in the Prevalence of Screen Time and Its Association With Biopsychosocial Risk Factors Among Korean Adolescents, 2008–2021 2023
- Trends in hypertension prevalence, awareness, treatment, and control in South Korea, 1998–2021: a nationally representative serial study 2023
- Prevalence and Mortality Risk of Neurological Disorders during the COVID-19 Pandemic: An Umbrella Review of the Current Evidence 2023
- Hydrogen Sulfide: Physiological Roles and Therapeutic Implications against COVID-19 2023